filmov
tv
Tailoring Targeted Therapy: New Directions for Managing Patients Across the Spectrum of NSCLC
Показать описание
Medscape
Рекомендации по теме
1:31:34
Tailoring Targeted Therapy: New Directions for Managing Patients Across the Spectrum of NSCLC
1:00:53
New Directions in the Treatment of Breast Cancer: Bringing Biology to the Clinic and Back
0:06:19
AML: The Next Generation of Tailored Therapy | MedscapeTV
1:18:32
Advanced GI Cancers: Identifying and Targeting Uncommon but Actionable Genomic Alterations
0:56:21
CCF Webinar: New Directions in Treating IDH1-Mutant Cholangiocarcinoma
0:02:10
Testing and Targeted Therapy in Triple Negative Breast Cancer: 2023 West Oncology
0:18:32
Mesothelioma: Old habits, new directions
0:26:51
Richter’s Syndrome: Risk, predictors, and treatment
1:04:50
New Directions in Cancer Diagnosis and Treatment
0:55:05
Novel Targeted Therapy for Low-Grade Lymphoid Malignancies in Older Adults by Dr. Krem
0:57:49
Understanding HER2 Alterations in Advanced Non-Squamous NSCLC
1:00:01
Webinar: Targeting the FGFR pathway: Infigratinib in cholangiocarcinoma
1:04:36
Gene Fusions & Other Key Genomic Alterations in Solid Tumors: Optimal Targeted Treatment
0:59:32
Breast Cancer 360: Genomic Testing and New Directions for Treatment
0:15:52
Debate: Are novel targets such as HER2 ready for prime time in colorectal cancer? - No
0:33:02
Targeted Therapy: BRAF and Beyond
1:01:13
Molecular Profiling Identifies Targeted Therapy Opportunities in Pediatric Solid Cancer
0:56:43
Moving Immunotherapy into the neo-adjuvant/adjuvant setting
0:47:17
New Directions in Treating Multiple Myeloma in the Era of Novel Agents
1:03:02
Novel Therapies & New Directions in Pancreas Cancer, 2024 - Eileen O’Reilly, MD
0:37:46
Current and Future Directions for Novel Therapy for Multiple Myeloma: Paul G. Richardson, MD
0:39:01
Future Directions for Targeted Therapy - BRAF, NRAS, and more
0:26:33
Targeted therapy of lung cancer with or without driver mutations
0:53:33
Oncology Sneak Preview Exclusive Insights on Upcoming Data, Developments & Discussions
1:31:34
1:00:53
0:06:19
1:18:32
0:56:21
0:02:10
0:18:32
0:26:51
1:04:50
0:55:05
0:57:49
1:00:01
1:04:36
0:59:32
0:15:52
0:33:02
1:01:13
0:56:43
0:47:17
1:03:02
0:37:46
0:39:01
0:26:33
0:53:33